Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative SOX vs XELOX in Localized Advanced Gastric Cancer
NCT01516944Phase 3Completed
- Sponsor
- Hebei Medical University
- Start
- Feb 2012
- Primary completion
- Apr 2018
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur + gimeracil + oteracil in gastric cancer (GC), sponsored by Hebei Medical University. Started Feb 2012; status: completed.
02
Drugs
tegafur + gimeracil + oteracil
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01516944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516944.